GOOD
INDIA
TELANGANA
USFDA issues 7 observations to NATCO Pharma's Hyderabad facility

NATCO Pharma says the observations are believed to be procedural in nature and is confident of addressing them in time
The Hindu BusinessLine पर मूल खबर पढ़ें ↗